GLYCEMIC OUTCOMES OF REAL-WORLD MINIMED™ 780G SYSTEM USERS FROM LATIN AMERICA

被引：0
|
作者：
Castro, M. [1 ]
Van Den Heuvel, T. [2 ]
Arrieta, A. [3 ]
Castaneda, J. [3 ]
Grassi, B. [4 ]
Medina, A. Gomez [5 ]
Calliari, L. E. [6 ]
Denise, F. [7 ]
Raggio, M. [8 ]
Cohen, O. [9 ]
机构：
[1] Medtron LATAM, Diabet, Santiago, Chile
[2] Bakken Res Ctr, Medtron Diabet, Maastricht, Netherlands
[3] Medtron Bakken Res Ctr, Medtron Diabet Emea, Maastricht, Netherlands
[4] Pontificia Univ Catolica Chile, Nutr Diabet & Metab, Santiago, Chile
[5] Hosp Univ San Ignacio, Endocrinol Unit, Bogota, Colombia
[6] Santa Casa Sao Paulo Sch Med Sci, Pediat Endocrinol Unit, Sao Paulo, Brazil
[7] CPCLIN DASA Clin Res Ctr, Dept Diabet, Sao Paulo, Brazil
[8] Hosp Univ Austral, Hosp Materno Infantil Tigre, Buenos Aires, Argentina
[9] Medtron Int Trading Sarl, Medtron Diabet Emea, Tolochenaz, Switzerland
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
900
引用
收藏
页码：A108 / A109
页数：2
相关论文
共 50 条
  • [1] Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users
    Da Silva, Julien
    Lepore, Giuseppe
    Battelino, Tadej
    Arrieta, Arcelia
    Castaneda, Javier
    Grossman, Benyamin
    Shin, John
    Cohen, Ohad
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (02) : 113 - 119
  • [2] IMPROVED GLYCEMIC OUTCOMES WITH INCREASING AUTOMATION: A REAL-WORLD ANALYSIS OF PATIENTS TRANSITIONING FROM EARLIER MINIMED™ SYSTEMS TO THE MINIMED™ 780G SYSTEM
    Grassi, B.
    Gomez, A. M.
    Calliari, L. E.
    Denise, F.
    Raggio, M.
    Castro, M.
    Mcvean, J.
    Van Den Heuvel, T.
    Castaneda, J.
    Arrieta, A.
    Cohen, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A117 - A118
  • [3] Predictors of time in target glucose range in real-world users of the MiniMed™ 780G system
    Castaneda, J.
    Arrieta, A.
    van den Heuvel, T.
    Cohen, O.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S344 - S344
  • [4] Predictors of time in target glucose range in real-world users of the MiniMed 780G system
    Castaneda, Javier
    Mathieu, Chantal
    Aanstoot, Henk-Jan
    Arrieta, Arcelia
    Da Silva, Julien
    Shin, John
    Cohen, Ohad
    DIABETES OBESITY & METABOLISM, 2022, 24 (11): : 2212 - 2221
  • [5] REAL-WORLD OUTCOMES OF THE FIRST 1′000 USERS OF THE MINIMEDTM 780G SYSTEM
    Da Silva, J.
    Arrieta, A.
    Castaneda, J.
    Grosman, B.
    Cohen, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A18 - A18
  • [6] Significant Reduction in Real-World Nighttime Burden with the MiniMed 780G System (MM780G)
    Shin, John
    Dai, Zheng
    Sathiyanathan, Naveen Mathew Nathan
    Vigersky, Robert A.
    McVean, Jennifer
    DIABETES, 2024, 73
  • [7] Hyperglycemia from Real-World Dawn Phenomenon Is Nearly Eliminated with the MiniMed 780G System (MM780G)
    McVean, Jennifer
    Shin, John
    Niu, Fang
    Diaz-Garelli, Franck
    Vigersky, Robert A.
    DIABETES, 2024, 73
  • [8] The MiniMed 780G system adapts to substantial changes in daily routine: lessons from real-world users during Ramadan
    Al-Sofiani, M.
    Al-Guwaihis, A.
    Al-Shaikh, A.
    Adjene, A.
    Al-Amuddin, N.
    Mohannadi, D.
    Arrieta, A.
    Castaneda, J.
    Chaar, W.
    van den Heuvel, T.
    Cohen, O.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S392 - S392
  • [9] Glycaemic control is not affected by season in MiniMed 780G system users: a real world study from Italy
    Bosi, E.
    Voelker, B.
    Smaniotto, V.
    Arrieta, A.
    Castaneda, J.
    van den Heuvel, T.
    Cohen, O.
    DIABETOLOGIA, 2024, 67 : S406 - S407
  • [10] Real-world performance of the MiniMed™ 780G safe meal bolus feature
    Putcha, V.
    Benedetti, A.
    Roy, A.
    Lintereur, L.
    Grosman, B.
    Turksoy, K.
    Sathiyanathan, N.
    Liu, M.
    Dai, Z.
    Shin, J.
    Diaz-Garelli, F.
    Cohen, O.
    Vigersky, R.
    DIABETOLOGIA, 2024, 67 : S374 - S374
12345